Wu Ming-Ju相关文献与解析，生知库 | 链接生命科学的每一步

SGLT2 Inhibitors Mitigate Contrast-Induced Acute Kidney Injury in Diabetes: Clinical and Experimental Evidence

SGLT2抑制剂可减轻糖尿病患者造影剂诱发的急性肾损伤：临床和实验证据

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms27041684

Chung, Mu-Chi; Chang, Yu-Teng; Guo, Yi-Jia; Chung, Chi-Jung; Wu, Laing-You; Wu, Ming-Ju; Shieh, Jeng-Jer

Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II study

异体脂肪干细胞ELIXCYTE治疗慢性肾脏病的临床疗效和安全性：一项I/II期研究

期刊:Stem Cells Translational Medicine

影响因子:4.9

doi:10.1093/stcltm/szaf076

Lin, Yi-Chun; Hung, Yi-Pei; Tian, Ya-Chung; Wu, Ming-Ju; Lin, Han-Chun; Chen, Szu-Ying; Wu, Mai-Szu; Chiou, Hung-Yi

A real-world retrospective cohort study comparing brand-name febuxostat (feburic) and generic febuxostat (feuri)

一项真实世界的回顾性队列研究比较了品牌药非布司他（feburic）和通用名非布司他（feuri）

期刊:Science Progress

影响因子:2.9

doi:10.1177/00368504261433091

Tsai, Shang-Feng; Wu, Ming-Ju; Chen, Cheng-Hsu

发表日期：2026

文献求助收藏

Use of Sodium-Glucose Transport Protein 2 Inhibitors and the Incidence of Urolithiasis: A Multi-Database and Cross-Country Study in Patients With Type 2 Diabetes Mellitus

钠-葡萄糖协同转运蛋白2抑制剂的使用与2型糖尿病患者尿路结石发生率：一项多数据库跨国研究

期刊:Clinical Pharmacology & Therapeutics

影响因子:5.5

doi:10.1002/cpt.3626

Chung, Mu-Chi; Lin, Chia-Yen; Chang, Chao-Hsiang; Chang, Yi-Huei; Hsiao, Po-Jen; Lien, Chi-Shun; Wu, Laing-You; Wu, Ming-Ju; Shieh, Jeng-Jer; Hung, Peir-Haur; Chen, Hsin-Hua; Chung, Chi-Jung

Impact of the Mediterranean Diet on Glycemic Control, Body Mass Index, Lipid Profile, and Blood Pressure in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

地中海饮食对2型糖尿病患者血糖控制、体重指数、血脂谱和血压的影响：随机对照试验的荟萃分析

期刊:Nutrients

影响因子:5

doi:10.3390/nu17243908

Wu, Ming-Ju; Hung, Cheng-Hsien; Yong, Su-Boon; Ching, Gregory S; Hsu, Heng-Ju

Machine learning models to predict osteoporosis in patients with chronic kidney disease stage 3-5 and end-stage kidney disease

利用机器学习模型预测慢性肾脏病3-5期和终末期肾脏病患者的骨质疏松症

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-95928-5

Hsu, Chia-Tien; Huang, Chin-Yin; Chen, Cheng-Hsu; Deng, Ya-Lian; Lin, Shih-Yi; Wu, Ming-Ju

Optimizing α-galactosidase A enzyme cutoff for Fabry disease screening in chronic kidney disease patients: a single-center reassessment of diagnostic yield and cost-effectiveness

优化慢性肾病患者法布里病筛查中α-半乳糖苷酶A酶临界值：单中心诊断率和成本效益的重新评估

期刊:Renal Failure

影响因子:3

doi:10.1080/0886022X.2025.2566386

Tsai, Shang-Feng; Wu, Ming-Ju; Hsieh, Hsien-Hsu; Chen, Cheng-Hsu

发表日期：2025

文献求助收藏

Bone health, renal outcomes, and iron deficiency anaemia in proton pump inhibitor versus histamine-2 receptor antagonist users: a retrospective cohort study based on TriNetX global collaborative network data

质子泵抑制剂与组胺H2受体拮抗剂使用者骨骼健康、肾脏结局和缺铁性贫血的比较：一项基于TriNetX全球协作网络数据的回顾性队列研究

期刊:BMJ Open Gastroenterology

影响因子:2.9

doi:10.1136/bmjgast-2024-001723

Chen, To-Pang; Wu, Ming-Ju; Chen, Cheng-Hsu; Tsai, Shang-Feng

Real-World Data as External Control in Assessing the Efficacy of Allogeneic Adipose-Derived Stem Cells Therapy for Advanced Chronic Kidney Disease

真实世界数据作为外部对照，用于评估异体脂肪干细胞疗法治疗晚期慢性肾病的疗效

期刊:Cts-Clinical and Translational Science

影响因子:2.8

doi:10.1111/cts.70415

Lin, Yi-Chun; Hung, Yi-Pei; Tian, Ya-Chung; Wu, Ming-Ju; Lin, Han-Chun; Chen, Szu-Ying; Wu, Mai-Szu; Chiou, Hung-Yi

SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis

SGLT2抑制剂在2型糖尿病合并肝硬化患者中的应用及心肾结局

SGLT2 Inhibitors Mitigate Contrast-Induced Acute Kidney Injury in Diabetes: Clinical and Experimental Evidence

SGLT2抑制剂可减轻糖尿病患者造影剂诱发的急性肾损伤：临床和实验证据

Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II study

异体脂肪干细胞ELIXCYTE治疗慢性肾脏病的临床疗效和安全性：一项I/II期研究

A real-world retrospective cohort study comparing brand-name febuxostat (feburic) and generic febuxostat (feuri)

一项真实世界的回顾性队列研究比较了品牌药非布司他（feburic）和通用名非布司他（feuri）

Use of Sodium-Glucose Transport Protein 2 Inhibitors and the Incidence of Urolithiasis: A Multi-Database and Cross-Country Study in Patients With Type 2 Diabetes Mellitus

钠-葡萄糖协同转运蛋白2抑制剂的使用与2型糖尿病患者尿路结石发生率：一项多数据库跨国研究

Impact of the Mediterranean Diet on Glycemic Control, Body Mass Index, Lipid Profile, and Blood Pressure in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

地中海饮食对2型糖尿病患者血糖控制、体重指数、血脂谱和血压的影响：随机对照试验的荟萃分析

Machine learning models to predict osteoporosis in patients with chronic kidney disease stage 3-5 and end-stage kidney disease

利用机器学习模型预测慢性肾脏病3-5期和终末期肾脏病患者的骨质疏松症

Optimizing α-galactosidase A enzyme cutoff for Fabry disease screening in chronic kidney disease patients: a single-center reassessment of diagnostic yield and cost-effectiveness

优化慢性肾病患者法布里病筛查中α-半乳糖苷酶A酶临界值：单中心诊断率和成本效益的重新评估

Bone health, renal outcomes, and iron deficiency anaemia in proton pump inhibitor versus histamine-2 receptor antagonist users: a retrospective cohort study based on TriNetX global collaborative network data

质子泵抑制剂与组胺H2受体拮抗剂使用者骨骼健康、肾脏结局和缺铁性贫血的比较：一项基于TriNetX全球协作网络数据的回顾性队列研究

Real-World Data as External Control in Assessing the Efficacy of Allogeneic Adipose-Derived Stem Cells Therapy for Advanced Chronic Kidney Disease

真实世界数据作为外部对照，用于评估异体脂肪干细胞疗法治疗晚期慢性肾病的疗效